POC(Point of Care) 응고 검사 기기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 기기 유형별, 제품별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Point of Care Coagulation Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type, By Product, By End User, By Region and Competition, 2020-2030F
상품코드:1770873
리서치사:TechSci Research
발행일:2025년 07월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 POC(Point of Care) 응고 검사 기기 시장 규모는 2024년에 18억 4,000만 달러로 평가되었으며, 예측 기간 동안 CAGR 5.79%로 성장하여 2030년까지 25억 8,000만 달러에 달할 것으로 예측됩니다.
이 시장은 심부정맥혈전증(DVT), 폐색전증, 심근경색, 혈우병, 폰 빌레브란트병 등 혈전성 질환 및 출혈성 질환의 유병률 증가로 인해 강한 성장세를 보이고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
18억 4,000만 달러
시장 규모 : 2030년
25억 8,000만 달러
CAGR : 2025-2030년
5.79%
급성장 부문
소모품·액세서리
최대 시장
북미
고령화 및 생활습관 관련 요인으로 인해 점점 더 흔해지고 있는 이러한 질환은 특히 장기간 항응고 요법을 받는 환자에서 빈번하고 시기적절한 응고 모니터링이 요구됩니다. 응급실, 수술실, 항응고 클리닉, 재택의료에서 신속한 진단의 필요성은 몇 분 안에 정확한 결과를 얻을 수 있는 POC(Point-of-Care) 응고 검사 기기에 대한 수요를 증가시키고 있습니다.
이 시장을 주도하는 두드러진 트렌드는 헬스케어 산업에서 분산형 진단으로의 전환으로, 기존의 중앙 집중식 실험실 검사보다 휴대가 간편하고 사용하기 쉬운 기기가 선호되고 있다는 점입니다. 이러한 변화는 임상적 의사결정을 강화하고, 절차의 지연을 최소화하며, 다양한 의료 환경에서 환자 치료를 개선하는 데 도움을 주고 있습니다.
The Global Point of Care Coagulation Testing Devices Market was valued at USD 1.84 Billion in 2024 and is projected to reach USD 2.58 Billion by 2030, growing at a CAGR of 5.79% during the forecast period. This market is experiencing strong momentum, driven by the growing prevalence of thrombotic and bleeding disorders such as deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, hemophilia, and von Willebrand disease.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.84 Billion
Market Size 2030
USD 2.58 Billion
CAGR 2025-2030
5.79%
Fastest Growing Segment
Consumables & Accessories
Largest Market
North America
These conditions, increasingly common due to aging populations and lifestyle-related factors, demand frequent and timely coagulation monitoring-especially among patients undergoing long-term anticoagulant therapies. The need for rapid diagnostics in emergency rooms, surgical units, anticoagulation clinics, and home healthcare is fueling demand for point of care (POC) coagulation devices that deliver accurate results in minutes.
A notable trend driving this market is the healthcare industry's shift toward decentralized diagnostics, favoring portable, easy-to-use devices over traditional, centralized lab testing. This transformation is enhancing clinical decision-making, minimizing procedural delays, and improving patient care across a variety of care settings.
Key Market Drivers
Rising Prevalence of Cardiovascular and Hemostatic Disorders
The rising burden of cardiovascular diseases (CVDs) and hemostatic disorders is a primary growth catalyst. According to the World Health Organization, CVDs are responsible for approximately 17.9 million deaths annually, accounting for 32% of all global fatalities. One-third of these occur prematurely, before the age of 70.
In the United States alone, CVDs caused 930,000 deaths in 2020, making them the leading cause of mortality. Similarly, 2.2 million deaths across the Americas in 2021 were attributed to cardiovascular conditions. Despite a decline in mortality rates over recent decades, the absolute number of cases remains high, driven by aging populations and lifestyle-related risk factors.
Key Market Challenges
High Cost of Devices and Consumables
One of the most significant barriers to market growth is the high cost associated with POC coagulation testing systems. These devices often involve substantial upfront capital investment, particularly when equipped with wireless connectivity, data integration tools, and automated features.
Recurring expenses on test cartridges, reagents, maintenance, and software updates further strain hospital and clinic budgets-particularly in low-resource settings and developing regions. For home users, the cost of consumables over time can lead to reduced testing frequency or non-compliance, which compromises treatment safety and outcomes.
In public healthcare systems where budgets are constrained, procurement decisions often prioritize cost over long-term clinical value. Reimbursement inconsistencies further discourage adoption of these technologies in outpatient and remote care environments. Additionally, premium-priced consumables for advanced coagulation tests such as TEG and ROTEM are often limited to larger, better-funded hospitals.
Key Market Trends
Integration of Digital Connectivity and Telehealth Solutions
One of the most transformative trends reshaping this market is the digital evolution of POC coagulation devices. Modern analyzers now feature Bluetooth and Wi-Fi capabilities, allowing for instant transmission of results to electronic health record (EHR) systems or secure cloud platforms.
This connectivity enables remote patient monitoring, particularly for individuals on anticoagulants such as warfarin or DOACs. Physicians can monitor INR/PT levels in real time, adjust dosages, and enhance treatment compliance-all without in-person visits.
Smartphone apps paired with these devices offer:
Guided test procedures
Visual display of results
Trend analysis
Real-time alerts and notifications
This ecosystem supports telehealth platforms, enabling virtual consultations and improving access in rural or home-based settings. Remote diagnostics, firmware updates, and device troubleshooting via apps are also streamlining usability and reducing support burdens.
Key Market Players
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Werfen, S.A.
Siemens Healthineers
Helena Laboratories Corporation
Medtronic plc
Koninklijke Philips N.V.
Alere Inc.
HemoSonics, LLC
Sysmex Corporation
Market Segmentation
By Device Type:
Anticoagulation Monitoring Devices
Platelet Function Monitoring Devices
Viscoelastic Coagulation Monitoring Devices
Others
By Product:
Instruments/Analyzers
Consumables & Accessories
By End User:
Hospitals
Clinics
Home Care Settings
Others
By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
The report provides detailed profiles and strategic insights for leading companies operating in the Global Point of Care Coagulation Testing Devices Market. Analysis includes product innovation, market positioning, technological advancements, and global footprint.
Available Customizations
TechSci Research offers customizable elements in this report to align with specific business needs. Available options include:
In-depth analysis and profiling of up to five additional market players
Let me know if you'd like this version adapted into a presentation deck, executive summary, or slide notes for a meeting!
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Point of Care Coagulation Testing Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device Type (Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices, Others)
5.2.2. By Product (Instruments/Analyzers, Consumables & Accessories)
5.2.3. By End User (Hospitals, Clinics, Home Care Settings, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Point of Care Coagulation Testing Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Device Type
6.2.2. By Product
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Point of Care Coagulation Testing Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Device Type
6.3.1.2.2. By Product
6.3.1.2.3. By End User
6.3.2. Mexico Point of Care Coagulation Testing Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Device Type
6.3.2.2.2. By Product
6.3.2.2.3. By End User
6.3.3. Canada Point of Care Coagulation Testing Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Device Type
6.3.3.2.2. By Product
6.3.3.2.3. By End User
7. Europe Point of Care Coagulation Testing Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device Type
7.2.2. By Product
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Point of Care Coagulation Testing Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Device Type
7.3.1.2.2. By Product
7.3.1.2.3. By End User
7.3.2. Germany Point of Care Coagulation Testing Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Device Type
7.3.2.2.2. By Product
7.3.2.2.3. By End User
7.3.3. United Kingdom Point of Care Coagulation Testing Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Device Type
7.3.3.2.2. By Product
7.3.3.2.3. By End User
7.3.4. Italy Point of Care Coagulation Testing Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Device Type
7.3.4.2.2. By Product
7.3.4.2.3. By End User
7.3.5. Spain Point of Care Coagulation Testing Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Device Type
7.3.5.2.2. By Product
7.3.5.2.3. By End User
8. Asia-Pacific Point of Care Coagulation Testing Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device Type
8.2.2. By Product
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Point of Care Coagulation Testing Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Device Type
8.3.1.2.2. By Product
8.3.1.2.3. By End User
8.3.2. India Point of Care Coagulation Testing Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Device Type
8.3.2.2.2. By Product
8.3.2.2.3. By End User
8.3.3. South Korea Point of Care Coagulation Testing Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Device Type
8.3.3.2.2. By Product
8.3.3.2.3. By End User
8.3.4. Japan Point of Care Coagulation Testing Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Device Type
8.3.4.2.2. By Product
8.3.4.2.3. By End User
8.3.5. Australia Point of Care Coagulation Testing Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Device Type
8.3.5.2.2. By Product
8.3.5.2.3. By End User
9. South America Point of Care Coagulation Testing Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device Type
9.2.2. By Product
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Point of Care Coagulation Testing Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Device Type
9.3.1.2.2. By Product
9.3.1.2.3. By End User
9.3.2. Argentina Point of Care Coagulation Testing Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Device Type
9.3.2.2.2. By Product
9.3.2.2.3. By End User
9.3.3. Colombia Point of Care Coagulation Testing Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Device Type
9.3.3.2.2. By Product
9.3.3.2.3. By End User
10. Middle East and Africa Point of Care Coagulation Testing Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Device Type
10.2.2. By Product
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Point of Care Coagulation Testing Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Device Type
10.3.1.2.2. By Product
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Point of Care Coagulation Testing Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Device Type
10.3.2.2.2. By Product
10.3.2.2.3. By End User
10.3.3. UAE Point of Care Coagulation Testing Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Device Type
10.3.3.2.2. By Product
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions: Conflicts, Pandemics and Trade Barriers
